Illumina, Inc. announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.
Cowen’s Liquid Biopsy Summit
Thursday, September 24, 2020 at 9:30am Pacific Time
The live webcasts can be accessed in the Investor Info section of Illumina’s web site under the “company” tab at www.illumina.com. A replay of the presentations will be posted on Illumina’s website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005895/en/
Investors:
Jacquie Ross, CFA
+1.858.882.2172
ir@illumina.com
Media:
Dr. Karen Birmingham
+44.7500.105665
kbirmingham@illumina.com
Source: Illumina, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20200923005895/en
